Cargando…

Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long‐Term Follow‐Up of the REDUCE‐MVI Trial

BACKGROUND: Off‐target properties of ticagrelor might reduce microvascular injury and improve clinical outcome in patients with ST‐segment–elevation myocardial infarction. The REDUCE‐MVI (Evaluation of Microvascular Injury in Revascularized Patients with ST‐Segment–Elevation Myocardial Infarction Tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Hoeven, Nina W., Janssens, Gladys N., Everaars, Henk, Nap, Alexander, Lemkes, Jorrit S., de Waard, Guus A., van de Ven, Peter M., van Rossum, Albert C., Escaned, Javier, Mejia‐Renteria, Hernan, ten Cate, Tim J. F., Piek, Jan J., von Birgelen, Clemens, Valgimigli, Marco, Diletti, Roberto, Riksen, Niels P., Van Mieghem, Nicolas M., Nijveldt, Robin, van Leeuwen, Maarten A. H., van Royen, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335553/ https://www.ncbi.nlm.nih.gov/pubmed/32122216 http://dx.doi.org/10.1161/JAHA.119.014411

Ejemplares similares

Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI Study
por: Janssens, Gladys N., et al.
Publicado: (2016)

Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions
por: Demirkiran, Ahmet, et al.
Publicado: (2021)

Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction
por: Konijnenberg, Lara S F, et al.
Publicado: (2020)

Strain analysis is superior to wall thickening in discriminating between infarcted myocardium with and without microvascular obstruction
por: Everaars, Henk, et al.
Publicado: (2018)

Invasive minimal Microvascular Resistance Is a New Index to Assess Microcirculatory Function Independent of Obstructive Coronary Artery Disease
por: de Waard, Guus A., et al.
Publicado: (2016)

The influence of microvascular injury on T1- and T2*-relaxation times after acute myocardial infarction
por: Robbers, Lourens, et al.
Publicado: (2014)

Diastolic-systolic velocity ratio to detect coronary stenoses under physiological resting conditions: a mechanistic study
por: de Waard, Guus A, et al.
Publicado: (2019)

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
por: Alexopoulos, Dimitrios, et al.
Publicado: (2013)

Coronary pressure and flow relationships in humans: phasic analysis of normal and pathological vessels and the implications for stenosis assessment: a report from the Iberian–Dutch–English (IDEAL) collaborators
por: Nijjer, Sukhjinder S., et al.
Publicado: (2016)

The Salmonella typhimurium locus mviA regulates virulence in Itys but not Ityr mice: functional mviA results in avirulence; mutant (nonfunctional) mviA results in virulence
Publicado: (1991)

Interindividual Variations in the Adenosine‐Induced Hemodynamics During Fractional Flow Reserve Evaluation: Implications for the Use of Quantitative Flow Ratio in Assessing Intermediate Coronary Stenoses
por: Mejía‐Rentería, Hernán, et al.
Publicado: (2019)

Impact of stenosis resistance and coronary flow capacity on fractional flow reserve and instantaneous wave-free ratio discordance: a combined analysis of DEFINE-FLOW and IDEAL
por: Stegehuis, Valérie, et al.
Publicado: (2023)

Comparison of Doppler Flow Velocity and Thermodilution Derived Indexes of Coronary Physiology
por: Demir, Ozan M., et al.
Publicado: (2022)

Value of Hybrid Imaging with PET/CT to Guide Percutaneous Revascularization of Chronic Total Coronary Occlusion
por: Stuijfzand, Wijnand J., et al.
Publicado: (2015)

Ticagrelor and prasugrel are independent predictors of improved long‐term survival in ACS patients
por: Gager, Gloria M., et al.
Publicado: (2020)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2022)

Comparative Effectiveness of Ticagrelor, Prasugrel, and Clopidogrel for Secondary Prophylaxis in Acute Coronary Syndrome: A Propensity Score‐Matched Cohort Study
por: Kumar, Arun, et al.
Publicado: (2022)

The influence of microvascular injury on native T1 and T2* relaxation values after acute myocardial infarction: implications for non-contrast-enhanced infarct assessment
por: Robbers, Lourens F. H. J., et al.
Publicado: (2017)

Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study
por: Alexopoulos, Dimitrios, et al.
Publicado: (2015)

Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study
por: Winter, Max-Paul, et al.
Publicado: (2019)

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)

Mismatch Between Cardiac Magnetic Resonance Imaging and Invasive Physiology
por: Everaars, Henk, et al.
Publicado: (2020)

Objective Identification of Intermediate Lesions Inducing Myocardial Ischemia Using Sequential Intracoronary Pressure and Flow Measurements
por: Stegehuis, Valérie E., et al.
Publicado: (2020)

Residual Quantitative Flow Ratio to Estimate Post‐Percutaneous Coronary Intervention Fractional Flow Reserve
por: van Diemen, Pepijn A., et al.
Publicado: (2021)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Long‐Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Cassese, Salvatore, et al.
Publicado: (2020)

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
por: Dai, Lulu, et al.
Publicado: (2022)

Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
por: Koch, Tobias, et al.
Publicado: (2023)

Real‐World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
por: Yildirim, Mustafa, et al.
Publicado: (2023)

The role of coronary angiography in out-of-hospital cardiac arrest patients in the absence of ST-segment elevation: A literature review
por: Spoormans, E. M., et al.
Publicado: (2020)

Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
por: Olechowski, Bartosz, et al.
Publicado: (2016)

Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis
por: Wen, Mingxiang, et al.
Publicado: (2020)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Publicado: (2019)

The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis
por: Guan, Baoyi, et al.
Publicado: (2022)

Thrombogenicity and endothelial progenitor cells function during Acute myocardial infarction - comparison of Prasugrel versus Ticagrelor
por: Wiessman, Maya, et al.
Publicado: (2023)

Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?
por: Broeders, Wieteke, et al.
Publicado: (2022)

De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early?
por: Masiero, Giulia, et al.
Publicado: (2020)

Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017
por: Rezaei, Safoura Sheikh, et al.
Publicado: (2020)

Imatinib attenuates reperfusion injury in a rat model of acute myocardial infarction
por: Konijnenberg, Lara S. F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a78vondibmub6d5i3kvh6n9e70